Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4726
Clean Energy Fuels
CLNE
$410M
| $244K | ﹤0.01% |
117,434
-46,645
| -28% | -$108K |
|
|
DVAX
4727
DELISTED
Dynavax Technologies
DVAX
| $244K | ﹤0.01% |
68,340
+19,205
| +39% | +$74.5K |
|
4728
Financial Institutions
FISI
$838M
| $244K | ﹤0.01% |
8,075
-2,223
| -22% | -$65.1K |
|
4729
Direxion Daily Technology Bull 3x ETF
TECL
$5.32B
| $244K | ﹤0.01% |
14,620
-35,660
| -71% | -$594K |
|
4730
PUT
Buckle
BKE
$2.37B
| $243K | ﹤0.01% |
11,800
+9,900
| +521% | +$190K |
|
4731
CALL
Myriad Genetics
MYGN
$285M
| $243K | ﹤0.01% |
8,500
-115,900
| -93% | -$3.38M |
|
|
PINC
4732
PUT
DELISTED
Premier
PINC
| $243K | ﹤0.01% |
+8,400
| New | +$313K |
|
4733
Vodafone
VOD
$35.9B
| $243K | ﹤0.01% |
12,207
-2,173,686
| -99% | -$39.4M |
|
4734
Astrana Health
ASTH
$1.78B
| $243K | ﹤0.01% |
13,790
+9,719
| +239% | +$166K |
|
|
CHNG
4735
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $243K | ﹤0.01% |
20,075
-429,925
| -96% | -$5.91M |
|
4736
CALL
iShares US Regional Banks ETF
IAT
$682M
| $242K | ﹤0.01% |
5,200
+200
| +4% | +$9.1K |
|
|
CEPU
4737
Central Puerto
CEPU
$2.24B
| $241K | ﹤0.01% |
81,867
+38,367
| +88% | +$226K |
|
4738
CALL
Check Point Software Technologies
CHKP
$12.6B
| $241K | ﹤0.01% |
2,200
-2,900
| -57% | -$323K |
|
4739
i3 Verticals
IIIV
$418M
| $241K | ﹤0.01% |
11,937
+4,070
| +52% | +$100K |
|
4740
Independent Bank Corp
IBCP
$793M
| $240K | ﹤0.01% |
11,277
-3,464
| -23% | -$72.2K |
|
|
AKCA
4741
DELISTED
Akcea Therapeutics Inc
AKCA
| $240K | ﹤0.01% |
15,591
+7,568
| +94% | +$161K |
|
4742
DigitalBridge
DBRG
$2.93B
| $239K | ﹤0.01% |
9,929
-76,794
| -89% | -$1.59M |
|
|
AVID
4743
DELISTED
Avid Technology Inc
AVID
| $239K | ﹤0.01% |
38,613
+7,615
| +25% | +$59.6K |
|
4744
Kodiak Sciences
KOD
$2.49B
| $238K | ﹤0.01% |
16,578
-705
| -4% | -$9.21K |
|
|
STR
4745
DELISTED
Sitio Royalties
STR
| $238K | ﹤0.01% |
10,376
+2,659
| +34% | +$74K |
|
4746
PUT
US Bancorp
USB
$99.6B
| $238K | ﹤0.01% |
4,300
-67,500
| -94% | -$3.65M |
|
4747
Live Oak Bancshares
LOB
$2.03B
| $237K | ﹤0.01% |
13,052
-3,894
| -23% | -$70.1K |
|
4748
Magnachip Semiconductor
MX
$127M
| $237K | ﹤0.01% |
23,400
-25,666
| -52% | -$270K |
|
4749
PUT
Insperity
NSP
$2.05B
| $237K | ﹤0.01% |
2,400
+1,500
| +167% | +$163K |
|
4750
UroGen Pharma
URGN
$1.88B
| $237K | ﹤0.01% |
9,954
-2,172
| -18% | -$71K |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.